x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2011 > Leukaemia and Lymphoma
Print

Description

Chairs: M.F. Fey, CH - J.M. Connors, CA
Hosting Chair: F. Cavalli, CH



Dear Colleagues,

Over the past twenty years or so, this course has become a renowned programme for physicians and scientists with an interest in the diagnosis and treatment of haematological cancers.

The international faculty, including ICML key note lecturers, will guide us through the complexity of the biology and the most relevant clinical problems in leukaemia and lymphoma, offering plenary lectures, practice-oriented training through case presentations, workshops in small groups and ample discussion slots.
The format of the residential course will furthermore offer opportunities for informal exchange of ideas, views and experience among the participants and with the faculty.

The close co-operation between the ESO Course Chairmen and the ICML Committee will assure an optimal co-ordination of the topics between the course and the ICML Congress.  A particular feature of the course will be to include topics and presentations that are important in the field but benefit from the smaller format emphasising clinical judgment and individualisation of treatment in contrast to a large and busy conference.

Attendance to the course will be by registration on a first-come/first-served basis. However, to respect the layout and objectives of the course, attendance will be limited to 80 participants.

We are much looking forward to meeting and working with you at the beautiful campus on Monte Verità near Ascona, in the lovely Italian-speaking South of Switzerland.

Yours sincerely,

Martin F. Fey, MD                                          Joseph Connors, MD
Course Chairman                                          Course Chairman


PARTICIPANTS' PROFILE

The programme is designed for postgraduate medical doctors at any stage of clinical career who are interested in haematological oncology. A mix of experienced clinicians or pathologists etc., and oncology/haematology trainees is welcome.
Scientists (PhD) are very welcome too, but they should be advised that the course will emphasise clinical aspects rather than basic biology.


LEARNING OBJECTIVES
After the course, participants should be able to:
 
- Identify the current clinical issues in haematological cancers as well as the   “burning research questions”,
- Discuss the value of pathology and molecular biology in the diagnosis and   prognosis of haematological neoplasms,
- Understand the principles of the molecular and cellular biology of leukaemias   and lymphoma,
- Summarise the most important clinical studies and data on lymphoma and   leukaemia.

General information

ORGANISING SECRETARIAT AND REGISTRATION
European School of Oncology
ESO Bellinzona Office
Ospedale Regionale, CH-6500 Bellinzona, Switzerland
Ph: +41 91 811 8050 - Fax: +41 91 811 8051
Emails:
dknupfer@eso.net, lrichetti@eso.net


VENUE
The course will be held at the Centro Congressi Monte Verità (www.monteverita.org) in Ascona (Southern Switzerland) located on a beautiful hill overlooking Ascona and the Lago Maggiore.
The airport of reference is Lugano. The Malpensa Airport will not be served with transfers.


ARRIVAL AND DEPARTURE TRANSFERS

Transfers will be organised at given times for arrivals on Sunday, 12 June and for departures on Tuesday, 14 June as indicated in the tables below.
After having registered to the course, participants will be offered the option to register to the transfers as well.


Arrivals - Sunday, 12 June

Location 

Pick up time 

Arrival at venue 

Lugano airport 

 10:00 

 11:00 

Lugano railway station

10:15

11:00

Locarno railway station

 12:15

 12:45

Lugano airport

 14:00

 15:00

Lugano railway station

 14:15

 15:00

Locarno railway station

 14:15

 14:45


Departures - Tuesday, 14 June

From course venue to:

Departure time 

Arrival time 

Lugano airport

 12:45

  14:00 

Lugano railway station

 12:45

 14:00

Locarno railway station

 13:00

 13:30


CME ACCREDITATION
All participants will be issued a certificate of attendance at the close of the conference.
The course has been appraised and approved by the Accreditation Council of Oncology in Europe (ACOE) acknowledging the quality of the scientific programme and its educational value. ACOE is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).
The course on Leukaemia and Lymphoma has been awarded 12 European Continuing Medical Education Credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, the participant should contact the AMA.
Furthermore, the course has been accredited with 10 ESMO-MORA points Category 1.


HANS WYDER FELLOWSHIPS
A limited number of Hans Wyder fellowships were available to cover registration, accommodation (in sharing room) and travel costs.
Fellowships are restricted to participants below the age of 40 coming from countries defined as low-income economies by the World Bank
http://data.worldbank.org/about/country-classifications/country-and-lending-groups
To apply for a fellowship, please provide ESO by 1st March 2011 with your short CV (including date of birth), letter describing the motivation to attend the course and an indication of the amount required to cover travel costs.

The deadline to apply for a fellowship has now passed (1st March 2011).


INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the course. Participants are advised to take out their own personal and travel insurance coverage.
 

11th INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMA
The ESO course is held in co-operation with the Organising Committee and will precede the
11th ICML (15-18 June 2011, Lugano, Switzerland). The 11-ICML conference will provide the worldwide most important forum for the discussion of all aspects relating to malignant lymphoma.
ICML and the ESO course are two separate events that require registration to one or the other, or both.
For further information please contact
cristiana.brentan@lymphcon.ch or visit www.lymphcon.ch

Faculty list

FACULTY
P. Boffetta, Mount Sinai School of Medicine, Department of Medicine, Hematology and Medical Oncology, New York, US
F. Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
B.D. Cheson, Georgetown University Hospital, Department of Hematology, Washington, D.C., US
J.M. Connors, University of British Columbia Cancer Agency, Lymphoma Tumor Group, Vancouver, CA
M.F. Fey, Berne University, Inselspital, Department of Medical Oncology, Berne, CH
M. Ghielmini, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
R. Herrmann, University Hospital, Department of Oncology, Basel, CH
C.W. Hess, Berne University, Inselspital, Department of Neurology, Berne, CH
D.K. Hossfeld, Medical University, Dept. of Oncology-Haematology, Hamburg, DE
T.A. Lister, St. Bartholomew's Hospital, Department of Medical Oncology, London, UK
L. Mazzucchelli, Cantonal Institute of Pathology in Southern Switzerland, Locarno, CH
B. Möller, Berne University, Inselspital, Department for Rheumatology & Clin. Immunology, Berne, CH
A. Neubauer, Philipps University, Department of Hematology/Oncology, Marburg, DE
J.R. Passweg, Geneva University Hospital, Department of Hematology, Geneva, CH
S. Stilgenbauer, University of Ulm, Department  of Internal Medicine 3, Haematology and Oncology, Ulm, DE
J.M. Vose, University of Nebraska Medical Centre, Hematology-Oncology Section, Nebraska, US

Programme


12 JUNE

 Registration

15:40 

Principles of lymphoma epidemiology 
P. Boffetta, US

16:00

Principles of pathology and microscopic diagnosis
of lymphoma 
L. Mazzucchelli, CH

16:30  Problems of the design and interpretation of phase II and III trials   
J.M. Connors, CA
17:00 

Coffee break

17:30  Workshop sessions (4 groups, rotating)
 Diagnosis and therapy in lymphoma
M.F. Fey, CH
- Case presentations 
Discussant: T.A. Lister, UK
 Diagnosis and therapy in lymphoma 
F. Cavalli, CH
- Case presentations 
Discussant: J.M. Connors, CA
 Diagnosis and treatment in leukaemia
J.R. Passweg, CH
- Case presentations 
Discussant: A. Neubauer, DE
 Microscopy course blood films and bone marrow  
S. Stilgenbauer, DE
19:30  Dinner

 

13 JUNE

17:30Workshop sessions (4 groups, rotating)
 Diagnosis and therapy in lymphoma
M.F. Fey, CH
- Case presentations 
Discussant: T.A. Lister, UK
 Diagnosis and therapy in lymphoma 
F. Cavalli, CH
- Case presentations 
Discussant: J.M. Connors, CA
 Diagnosis and treatment in leukaemia
J.R. Passweg, CH
- Case presentations 
Discussant: A. Neubauer, DE
 Microscopy course blood films and bone marrow  
S. Stilgenbauer, DE

10:00

Coffee break

10:30

Targeted therapy in leukaemia: New avenues 
A. Neubauer, DE

11:00

Multimodal therapy in haemato-oncology
Chair: M.F. Fey, CH
 Lymphoma in patients with rheumatological disorders 
B. Möller, CH
 Renal problems in patients treated for haematological malignancy 
J.M. Vose, US
 Neurological problems in patients with haematological neoplasms 
C.W. Hess, CH

12:30

Lunch 
13:45Transatlantic differences in the treatment of Hodgkin's disease 
J.M. Connors, CA
14:15Plenary case discussions 
 

Case presentations
F. Cavalli, CH
Discussants: J. M. Connors, CA   M.F. Fey, CH and confirmed faculty

15:45Coffee break 
16:15Workshop sessions (4 gtoups rotating) 
 Diagnosis and therapy in lymphoma
M.F. Fey, CH
- Case presentations 
Discussant: T.A. Lister, UK
 Diagnosis and therapy in lymphoma 
R. Hermann, CH
- Case presentations 
Discussant: M. Ghielmini, CH
 Diagnosis and treatment in leukaemia
J.R. Passweg, CH
- Case presentations 
Discussant: A. Neubauer, DE
 Microscopy course blood films and bone marrow  
S. Stilgenbauer, DE
17:45Problems of the design and interpretation of very early clinical trials in hemato-oncology  
B.D. Cheson, US
18:15Treatment of lymphomas in elderley patients 
J.M. Vose, US

19:15   

Dinner 

14 JUNE

17:30Workshop sessions (4 groups, rotating)
 Diagnosis and therapy in lymphoma
M.F. Fey, CH
- Case presentations 
Discussant: D.K. Hossfeld, DE 
 Diagnosis and therapy in lymphoma 
R. Hermann, CH
- Case presentations 
Discussant: M. Ghielmini, CH
 Diagnosis and treatment in leukaemia
J.R. Passweg, CH
- Case presentations 
Discussant: A. Neubauer, DE
 Microscopy course blood films and bone marrow  
S. Stilgenbauer, DE
10:00Coffee break
 Plenary case discussions
 Case presetations
M.F. Fey, CH
Discussants: R. Herrmann, CH - D.K. Hossfeld, DE 
S. Stilgenbauer, DE and confirmed faculty
12:30Departures